Peer Review reports
From: SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway
| Original Submission | ||
|---|---|---|
| 31 Jan 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 27 Feb 2023 | Reviewed | Reviewer Report |
| 16 Apr 2023 | Reviewed | Reviewer Report |
| 5 May 2023 | Author responded | Author comments - Xinyu Wang |
| Resubmission - Version 3 | ||
| 5 May 2023 | Submitted | Manuscript version 3 |
| 29 May 2023 | Author responded | Author comments - Xinyu Wang |
| Resubmission - Version 4 | ||
| 29 May 2023 | Submitted | Manuscript version 4 |
| 1 Jun 2023 | Author responded | Author comments - Xinyu Wang |
| Resubmission - Version 5 | ||
| 1 Jun 2023 | Submitted | Manuscript version 5 |
| 20 Jun 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 21 Jun 2023 | Editorially accepted | |
| 26 Jun 2023 | Article published | 10.1186/s12885-023-11097-6 |
You can find further information about peer review here.